Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Kedudukan dalam Saham #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Universitรฉ de Montrรฉal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Harga Saham
$0.14942078
Disegerakkan terakhir: 2025-05-15
Modal Pasaran
$3.86M
Perubahan (1 hari)
0.10%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan Medigene AG (MDG1)

Kategori

Hasil untuk Medigene AG (MDG1)
Hasil pada Jun 2024 TTM: $7.99M
Menurut laporan kewangan terkini daripada Medigene AG, hasil semasa syarikat (TTM) ialah $7.99M. Pada tahun 2022, syarikat memperoleh hasil sebanyak $33.52M peningkatan berbanding hasil pada tahun 2021 iaitu $11.90M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Medigene AG dari 2004 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $7.99M 19.85%
2023 $6.67M -80.10%
2022 $33.52M 181.71%
2021 $11.90M 22.09%
2020 $9.75M -17.36%
2019 $11.79M 35.46%
2018 $8.71M -5.48%
2017 $9.21M 113.45%
2016 $4.32M 28.15%
2015 $3.37M -77.88%
2014 $15.22M 46.65%
2013 $10.38M 34.07%
2012 $7.74M 160.02%
2011 $2.98M 0.59%
2010 $2.96M -94.55%
2009 $54.28M 16.25%
2008 $46.70M 44.83%
2007 $32.24M -19.79%
2006 $40.20M 73.97%
2005 $23.11M 36.31%
2004 $16.95M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$12.62B 157,814.80%
US
$6.02B 75,219.06%
NL
- -
CH
- -
KR
$10.11B 126,373.78%
BE